Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
February, 2026
February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  
Emerging Evidence on Long-Term Oral Anticoagulation After Provoked VTE: Insights from the HI-PRO Trial
Anticoagulation Forum/LinkedIn
Sep 13, 2025, 13:36

Emerging Evidence on Long-Term Oral Anticoagulation After Provoked VTE: Insights from the HI-PRO Trial

Anticoagulation Forum shared on LinkedIn.

“Join us for our free October webinar: Emerging Evidence: Long-term oral anticoagulation following provoked VTE? A focus on the HI-PRO Trial

Tuesday, October 7, 2025 | 12:00 PM ET

Join us as expert faculty review findings from the recent HI-PRO Trial on the use of apixaban for extended treatment of provoked venous thromboembolism (VTE).

What you’ll learn:

  •  Key insights from trial design and results
  •  Clinical implications for real-world practice
  •  Patient selection considerations for extended therapy
  • Faculty:

Arthur Allen, PharmD, CACP – SALT LAKE CITY VA HEALTH CARE SYSTEM
Margaret Fang, MD, MPH – University of California, San Francisco
Gregory Piazza, MD, MS – Brigham and Women’s Hospital”

Emerging Evidence on Long-Term Oral Anticoagulation After Provoked VTE: Insights from the HI-PRO Trial

Register today here.

Read more on Hemostasis Today.

Anticoagulation Anticoagulation Forum Clinical Education Health Hematology Hemostasis Hemostasis Today Medicine Thrombosis Care VTE
NewsFeed